Does RISANKIZUMAB-RZAA Cause Nephrolithiasis? 569 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 569 reports of Nephrolithiasis have been filed in association with RISANKIZUMAB-RZAA. This represents 0.9% of all adverse event reports for RISANKIZUMAB-RZAA.
569
Reports of Nephrolithiasis with RISANKIZUMAB-RZAA
0.9%
of all RISANKIZUMAB-RZAA reports
0
Deaths
284
Hospitalizations
How Dangerous Is Nephrolithiasis From RISANKIZUMAB-RZAA?
Of the 569 reports, 284 (49.9%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 569 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Nephrolithiasis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA